OBJECTIVE: Overall health care resource utilization by adults with congenital heart disease has increased dramatically in the past two decades, yet little is known about utilization patterns at the end of life. The objective of this study is to better understand the patterns and influences on end-of-life care intensity for adults with congenital heart disease. METHODS: We identified a sample of adults with congenital heart disease (n = 65), cancer (n = 10 784), or heart failure (n = 3809) who died between January 2010 and December 2015, cared for in one multi-hospital health care system. We used multivariate analysis to evaluate markers of resource utilization, location of death, and documentation of advance care planning among patients with congenital heart disease versus those with cancer and those with heart failure. RESULTS: Approximately 40% of adults with congenital heart disease experienced inpatient and intensive care unit (ICU) hospitalizations in the last 30 days of life; 64% died in the hospital. Compared to patients with cancer, patients with adult congenital heart disease (ACHD) were more likely to have inpatient (adjusted risk ratio 1.57; 95% CI 1.12-2.18) and ICU admissions in the last 30 days of life (adjusted risk ratio 2.56; 95% CI 1.83-3.61), more likely to die in the hospital (adjusted risk ratio 1.75; 95% CI 1.43-2.13), and more likely to have documentation of advance care planning (adjusted risk ratio 1.46; 95% CI 1.09-1.96). Compared to patients with heart failure (HF), patients with ACHD were less likely to have an ICU admission in the last 30 days of life (adjusted risk ratio 0.73; 95% CI 0.54-0.99). CONCLUSIONS: Adults with congenital heart disease have significant hospital resource utilization near the end of life compared to patients with cancer, notable for more hospitalizations and a higher likelihood of death in the hospital. This population represents an important opportunity for the application of palliative and supportive care.
OBJECTIVE: Overall health care resource utilization by adults with congenital heart disease has increased dramatically in the past two decades, yet little is known about utilization patterns at the end of life. The objective of this study is to better understand the patterns and influences on end-of-life care intensity for adults with congenital heart disease. METHODS: We identified a sample of adults with congenital heart disease (n = 65), cancer (n = 10 784), or heart failure (n = 3809) who died between January 2010 and December 2015, cared for in one multi-hospital health care system. We used multivariate analysis to evaluate markers of resource utilization, location of death, and documentation of advance care planning among patients with congenital heart disease versus those with cancer and those with heart failure. RESULTS: Approximately 40% of adults with congenital heart disease experienced inpatient and intensive care unit (ICU) hospitalizations in the last 30 days of life; 64% died in the hospital. Compared to patients with cancer, patients with adult congenital heart disease (ACHD) were more likely to have inpatient (adjusted risk ratio 1.57; 95% CI 1.12-2.18) and ICU admissions in the last 30 days of life (adjusted risk ratio 2.56; 95% CI 1.83-3.61), more likely to die in the hospital (adjusted risk ratio 1.75; 95% CI 1.43-2.13), and more likely to have documentation of advance care planning (adjusted risk ratio 1.46; 95% CI 1.09-1.96). Compared to patients with heart failure (HF), patients with ACHD were less likely to have an ICU admission in the last 30 days of life (adjusted risk ratio 0.73; 95% CI 0.54-0.99). CONCLUSIONS: Adults with congenital heart disease have significant hospital resource utilization near the end of life compared to patients with cancer, notable for more hospitalizations and a higher likelihood of death in the hospital. This population represents an important opportunity for the application of palliative and supportive care.
Authors: Anne Walling; Karl A Lorenz; Sydney M Dy; Arash Naeim; Homayoon Sanati; Steven M Asch; Neil S Wenger Journal: J Clin Oncol Date: 2008-08-10 Impact factor: 44.544
Authors: Julia M Langton; Bianca Blanch; Anna K Drew; Marion Haas; Jane M Ingham; Sallie-Anne Pearson Journal: Palliat Med Date: 2014-05-27 Impact factor: 4.762
Authors: Daniel Tobler; Matthias Greutmann; Jack M Colman; Mehtap Greutmann-Yantiri; Lawrence S Librach; Adrienne H Kovacs Journal: Palliat Med Date: 2011-06-22 Impact factor: 4.762
Authors: Padma Kaul; Finlay A McAlister; Justin A Ezekowitz; Jeffrey A Bakal; Lesley H Curtis; Hude Quan; Merril L Knudtson; Paul W Armstrong Journal: Arch Intern Med Date: 2010-10-11
Authors: Kathleen T Unroe; Melissa A Greiner; Adrian F Hernandez; David J Whellan; Padma Kaul; Kevin A Schulman; Eric D Peterson; Lesley H Curtis Journal: Arch Intern Med Date: 2010-10-11
Authors: Elaine Y Lin; Hillel W Cohen; Ami B Bhatt; Ada Stefanescu; David Dudzinski; Doreen DeFaria Yeh; Jacob Johnson; George K Lui Journal: Congenit Heart Dis Date: 2014-10-31 Impact factor: 2.007
Authors: Michael D Seckeler; Tabitha G Moe; Ian D Thomas; Omar Meziab; Jennifer Andrews; Elissa Heller; Scott E Klewer Journal: Am J Cardiol Date: 2015-09-10 Impact factor: 2.778
Authors: Jill M Steiner; Christina Morse; Robert Y Lee; J Randall Curtis; Ruth A Engelberg Journal: J Pain Symptom Manage Date: 2020-06-26 Impact factor: 3.612
Authors: Jill M Steiner; Alysha Dhami; Crystal E Brown; Karen K Stout; J Randall Curtis; Ruth A Engelberg; James N Kirkpatrick Journal: Am J Cardiol Date: 2020-08-28 Impact factor: 2.778